Site Search
Search Results
Comprehensive Genomic Testing for Lung Cancer Patients: Pathologist-Driven Solutions
LUNGevity and ACS CAN partnered with Bruce Quinn Associates to develop materials to engage hospitals on pathologist-initiated biomarker testing, providing an overview of the MolDx clarification on CMS "treating physician" guidance. Comprehensive Genomic Testing for Lung Cancer Patients: Pathologist-Driven Solutions ...
Priority Issue
State
Policy Issue
- (-) Remove Research, Funding and Drug Development filter Research, Funding and Drug Development